• Ryan Center for Sports Medicine
  • Shapiro Ambulatory Center
  • Maximizing Athletic Performance

    Advanced Arthroscopic Surgery

  • Rebuilding Reliable Joints

    Shoulder Replacement & Complex Reconstruction

  • Maximizing Shoulder Range of Motion

    Advanced Cartilage Restoration

  • Helping You Achieve Your Goals

    Patient Centered Care & Excellent Outcomes

  • Play
  • Pause
Home / Research » Dexamethasone Modulates BMP-2 Effects on Mesenchymal Stem Cells In Vitro

Dexamethasone Modulates BMP-2 Effects on Mesenchymal Stem Cells In Vitro

Jager M, Fischer J, Dohrn W, Li X, Ayers DC, Czibere A, Prail WC, Lensing-Hohn S, Krauspe R.  Dexamethasone modulates BMP-2 effects on mesenchymal stem cells in vitro.  Journal of Orthopaedic Research.  2008 Nov;26(11): 1440-48.

Abstract
Dexamethasone/ascorbic acid/glycerolphosphate (DAG) and bone morphogenic protein (BMP)-2 are potent agents in cell proliferation and differentiation pathways. This study investigates the in vitro interactions between dexamethasone and BMP-2 for an osteoblastic differentiation of mesenchymal stem cells (MSCs). Bone marrow-derived human MSCs were cultured with DAG (group A), BMP-2 + DAG (group B), and DAG + BMP-2 combined with a porous collagen I/III scaffold (group C). RT-PCR, ELISA, immuncytochemical stainings and flow cytometry analysis served to evaluate the osteogenic-promoting potency of each of the above conditions in terms of cell morphology/viability, antigen presentation, and gene expression. DAG induced collagen I secretion from MSCs, which was further increased by the combination of DAG + BMP-2. In comparison, the collagen scaffold and the control samples showed no significant influence on collagen I secretion of MSCs. DAG stimulation of MSCs led also to a steady but not significant increase of BMP-2 level. A DAG and more, a DAG + BMP-2, stimulation increased the number of mesenchymal cells (CD105+/CD73+). All samples showed mRNA of ALP, osteopontin, Runx2, Twist 1 and 2, Notch-1/2, osteonectin, osteocalcin, BSP, and collagen-A1 after 28 days of in vitro culture. Culture media of all samples showed a decrease in Ca(2+) and PO(4) (2-) concentration, whereas a collagen-I-peak only occurred at day 28 in DAG- and DAG + BMP-2-stimulated bone marrow cells. In conclusion, BMP-2 enhances DAG-induced osteogenic differentiation in mesenchymal bone marrow cells. Both agents interact in various ways and can modify osteoblastic bone formation.
  • american-academy-orthopaedic-surgeons
  • american-orthopaedic-society-for-sports-med
  • Reserchgate
  • orthopaedic-research-society
  • american-arthroscopic-association-north-america
  • american-shoulder-and-elbow-surgeons
  • boston-medical-center
  • boston-university
  • boston-university-school-of-medicine
  • depuy-synthes
  • boston-university-orthopaedic-surgery
  • easter-orthopaedic-association
  • tornier